Filter
3003
Filtered Results: 3003
Text search:
patient
flow
Featured
Recommendations
361
New Publications
799
Language
Document type
No document type
1644
Guidelines
489
Studies & Reports
409
Manuals
197
Strategic & Response Plan
109
Training Material
63
Fact sheets
44
Situation Updates
20
Infographics
11
Brochures
7
Resource Platforms
6
Online Courses
4
Countries / Regions
India
225
Global
113
Kenya
102
South Africa
81
Liberia
79
Sierra Leone
75
Ethiopia
71
Nigeria
66
Uganda
64
Tanzania
56
Western and Central Europe
54
Malawi
49
Africa
48
Myanmar / Burma
46
Latin America and the Carribbean
39
Nepal
37
Rwanda
37
Ghana
36
Zambia
36
Syria
33
Bangladesh
33
Philippines
31
Guinea
29
Namibia
26
Ukraine
25
Zimbabwe
25
Eastern Europe
22
Congo, Democratic Republic of
20
South–East Asia Region
20
East and Southern Africa
20
West and Central Africa
17
South Sudan
16
Lesotho
15
Mozambique
15
Asia
13
Germany
12
Russia
12
Cambodia
11
Botswana
11
Burkina Faso
10
Senegal
9
Haiti
9
Middle East and North Africa
9
Indonesia
9
Venezuela
8
Mali
7
Madagascar
7
Eswatini/ Swaziland
7
Colombia
6
Cameroon
6
USA
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
Iraq
6
Brazil
5
Tajikistan
4
Albania
4
Argentina
4
Lebanon
4
Sudan
4
Yemen
4
Chad
4
China
3
Chile
3
Peru
3
Southern Africa
3
Côte d’Ivoire / Ivory Coast
3
Vietnam
3
Papua New Guinea
3
Somalia
3
Thailand
2
Turkey
2
Fiji
2
Laos
2
Jordan
2
North America
2
United Kingdom
2
Bolivia
2
Sri Lanka
2
Georgia
2
Angola
2
Pakistan
2
North Macedonia
1
Timor Leste/ East Timor
1
Serbia
1
Benin
1
Gambia
1
Kazakhstan
1
Iran
1
Canada
1
Singapore
1
Kyrgyzstan
1
Afghanistan
1
Burundi
1
Malaysia
1
Morocco
1
Bulgaria
1
Mauritania
1
Lithuania
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Moldova
1
Egypt
1
Greece
1
Palestine
1
Central African Republic
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1214
Clinical Guidelines
303
Public Health
181
Women & Child Health
126
Key Resources
119
Capacity Building
70
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
COVID-19
320
TB
194
HIV
190
Mental Health
142
Caregiver
130
Ebola
125
Rapid Response
115
NTDs
93
AMR
79
Pharmacy
78
NCDs
78
Conflict
76
Planetary Health
50
Refugee
41
Global Health Education
33
Disability
30
Natural Hazards
29
Cholera
29
Health Financing Toolbox
24
Specific Hazards
21
Zika
17
Social Ethics
13
Polio
13
South Sudan
1
Health Financing
1
Typhoon
1
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt...
The importance of robust mortality surveillance systems cannot be overstated in an era marked by increasing global health challenges where health threats loom large and population dynamics continue to evolve. Accurate and timely mortality data is essential for identifying trends and detecting emergi...
L'importance de systèmes de surveillance de la mortalité robustes ne peut être surestimée à une époque marquée par des défis sanitaires mondiaux croissants, où les menaces sanitaires pèsent lourd et la dynamique des populations continue d'évoluer. Des données précises et opportunes sur ...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Les médicaments ont été classés à la fois par classe pharmaco-thérapeutique et par ordre alphabétique. La présence d’une marque astérisque renvoie à davantage de précision pour le (les) médicament(s) concerné(s).
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diverse needs, enables efficient use of health system re...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
